At this point, we do not have a confirmation of the launch timeline and are working with the authorities concerned to finalise this." "If the price difference between the innovator product and the generic copycats is not significant, many will prefer to buy the innovator product," said Sheetal Sapale, vice-president, commercial, at industry tracker PharmaTrac
These comparisons reflect publicly available information as of June 2026 - pricing and platform details for all three can change, so verify current terms directly with any platform before enrolling
Parola M, Pinzani M
Once-Weekly Semaglutide in Adults With Overweight or Obesity
Hypoglycemia (low blood sugar) risk is increased when using a GLP-1 agonist, especially if also taking medications such as insulin or sulfonylureas
In Phase 2 trials, retatrutide was started at 12 mg subcutaneously once weekly and gradually titrated to maintenance doses of 4 mg, 8 mg, or 12 mg once weekly